Warning: The NCBI web site requires JavaScript to function. more...
World Antimalarial Resistance Network (WARN) IV: clinical pharmacology.
Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ.
Malar J. 2007 Sep 6;6:122.
Related citations
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d'Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ.
Malar J. 2007 Sep 6;6:119.
World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility.
Bacon DJ, Jambou R, Fandeur T, Le Bras J, Wongsrichanalai C, Fukuda MM, Ringwald P, Sibley CH, Kyle DE.
Malar J. 2007 Sep 6;6:120.
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.
Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ.
Malar J. 2007 Sep 6;6:121.
The rationale and plan for creating a World Antimalarial Resistance Network (WARN).
Sibley CH, Barnes KI, Plowe CV.
Malar J. 2007 Sep 6;6:118.
Antimalarial dosing regimens and drug resistance.
Barnes KI, Watkins WM, White NJ.
Trends Parasitol. 2008 Mar;24(3):127-34. Epub 2008 Feb 11. Review.
[Drug-resistant malaria: problems with its definition and technical approaches].
Basco L, Ringwald P.
Sante. 2000 Jan-Feb;10(1):47-50. French.
Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
Na-Bangchang K, Karbwang J.
Fundam Clin Pharmacol. 2009 Aug;23(4):387-409. Review.
A network to monitor antimalarial drug resistance: a plan for moving forward.
Sibley CH, Barnes KI, Watkins WM, Plowe CV.
Trends Parasitol. 2008 Jan;24(1):43-8. Epub 2007 Nov 26. Review.
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
Hoshen MB, Stein WD, Ginsburg HD.
Parasitology. 2001 Oct;123(Pt 4):337-46.
Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.
Gomes M, Ribeiro I, Warsame M, Karunajeewa H, Petzold M.
BMC Infect Dis. 2008 Mar 28;8:39. Review.
Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials.
Ménard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona LP, Raharimalala L, Domarle O, Randrianasolo L, Randriamanantena A, Jahevitra M, Andriantsoanirina V, Rason MA, Raherinjafy R, Rakotomalala E, Tuseo L, Raveloson A.
Malar J. 2008 Apr 4;7:55.
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Nyunt MM, Plowe CV.
Clin Pharmacol Ther. 2007 Nov;82(5):601-5. Epub 2007 Sep 26.
How can we do pharmacokinetic studies in the tropics?
Simpson JA, Aarons L, White NJ.
Trans R Soc Trop Med Hyg. 2001 Jul-Aug;95(4):347-51. Review.
[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.
Sante. 2008 Jan-Mar;18(1):43-7. French.
Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.
Edwards G, Winstanley PA, Ward SA.
Clin Pharmacokinet. 1994 Aug;27(2):150-65. Review.
The de novo selection of drug-resistant malaria parasites.
White NJ, Pongtavornpinyo W.
Proc Biol Sci. 2003 Mar 7;270(1514):545-54.
Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.
Simpson JA, Watkins ER, Price RN, Aarons L, Kyle DE, White NJ.
Antimicrob Agents Chemother. 2000 Dec;44(12):3414-24.
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.
Malar J. 2009 Jun 8;8:125.
Monitoring antimalarial resistance: launching a cooperative effort.
Sibley CH, Guerin PJ, Ringwald P.
Trends Parasitol. 2010 May;26(5):221-4. Epub 2010 Mar 20.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on